ReLIA Biological Engineering (Shanghai) Co., Ltd. of Shanghai at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

ReLIA Biological Engineering (Shanghai) Co., Ltd.

5th, Floor, Building 4, Zhongshan North Road, Hongkou District, 200437 Shanghai
Telephone +86 21 65248530
Fax +86 21 65249508

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.


jim Jin

Marketing Director

Shanghai, China



Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.02  Diagnostic rapid tests

Diagnostic rapid tests

About us

Company portrait

Since its foundation in 2001, ReLIA Biotech has been at the forefront of research in point of care testing technologies, with it’s primary research and development centre located in Silicon Valley, California. Currently, it holds its Asian Pacific headquarters at the Shekou Free Trade Zone, Shenzhen, as well as large scale production and R&D centers in Shenzhen and Jiangsu.

Under the guidance of Dr. Willian J. Rutter, our company’s founder, ReLIA has adhered to a diligent attitude towards research. We mold modern developments into technological advancement/systems, which promote rapid diagnostic services and improve the health and wellbeing of patients whilst simultaneously reducing medical costs.
Currently, the company focuses on two categories of rapid detection systems: The multi-functional immunoassay system and immunofluorescence detection system. Both of these systems cover the detection of biomarkers for cardiovascular, acute kidney injury and inflammatory related conditions.